Copyright
©The Author(s) 2021.
World J Gastrointest Surg. May 27, 2021; 13(5): 406-418
Published online May 27, 2021. doi: 10.4240/wjgs.v13.i5.406
Published online May 27, 2021. doi: 10.4240/wjgs.v13.i5.406
Figure 5 Pancreatic ductal adenocarcinoma.
A: The ducts show features of malignancy including cytologic atypia and incomplete gland formation with loss of lobular architecture, in a prominent desmoplastic stroma (hematoxylin & eosin, 130 ×, scale 250 µm); B: SMAD4 immunostaining shows loss of SMAD4 expression in the malignant glands (SMAD4, 120 ×, scale 250 µm).
- Citation: Aldyab M, El Jabbour T, Parilla M, Lee H. Benign vs malignant pancreatic lesions: Molecular insights to an ongoing debate. World J Gastrointest Surg 2021; 13(5): 406-418
- URL: https://www.wjgnet.com/1948-9366/full/v13/i5/406.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i5.406